These findings suggest that inhibition of a single synaptolytic factor, FAM19A5, even in the presence of external synapse disrupting factors, such as amyloid or pTau aggregates, can normalize the synaptic balance, restoring lost synapses and regaining impaired cognition across tauopathy and amyloidopathy conditions. Here, TAFA5 is linked to tauopathy.